journal article·2027-01

Synthetic polypeptide adjuvant-antibiotic combination eradicates polymicrobial assemblies, dormant bacteria and bacterial biofilm

Swagatam Barman, Md Waliullah Hossain, Aiswarya Chandrasseril Bansidhar, Ethan Older, Jie Li, Alan W. Decho, Chuanbing Tang

Biomaterials· Volume 336
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Antimicrobial agents and applications · Antimicrobial Peptides and Activities · Orthopedic Infections and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (50)

Show source-provided references
1. Antimicrobial resistance: a concise update10.1016/j.lanmic.2024.07.010 ↗
2. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 205010.1016/S0140-6736(24)01867-1 ↗
3. Intrinsic antimicrobial resistance: molecular biomaterials to combat microbial biofilms and bacterial persisters10.1016/j.biomaterials.2024.122690 ↗
4. Tolerance and resistance of microbial biofilms10.1038/s41579-022-00682-4 ↗
5. The biofilm life cycle: expanding the conceptual model of biofilm formation10.1038/s41579-022-00767-0 ↗
6. Co-infecting microorganisms dramatically alter pathogen gene essentiality during polymicrobial infection10.1038/nmicrobiol.2017.79 ↗
7. Human polymicrobial infections10.1016/S0140-6736(05)70155-0 ↗
8. The biogeography of polymicrobial infection10.1038/nrmicro.2015.8 ↗
9. Combining antibiotics to tackle antimicrobial resistance10.1038/s41564-025-01969-x ↗
10. The challenge of overcoming antibiotic resistance: an adjuvant approach?10.1021/acsinfecdis.7b00071 ↗
11. Systematic mapping of antibiotic cross-resistance and collateral sensitivity with chemical genetics10.1038/s41564-024-01857-w ↗
12. Antibiotic adjuvants: a versatile approach to combat antibiotic resistance10.1021/acsomega.3c00312 ↗
13. Polymers as advanced antibacterial and antibiofilm agents for direct and combination therapies10.1039/D1SC05835E ↗
14. Synergism between rifampicin and cationic polyurethanes overcomes intrinsic resistance of Escherichia coli10.1021/acs.biomac.1c00306 ↗
15. Membrane‐active metallopolymers: repurposing and rehabilitating antibiotics to gram‐negative superbugs
16. Amino-acid-conjugated polymer-rifampicin combination: effective at tackling drug-resistant gram-negative clinical isolates10.1021/acsabm.9b00732 ↗
17. Antimicrobial metallopolymers and their bioconjugates with conventional antibiotics against multidrug-resistant bacteria10.1021/ja5011338 ↗
18. Pentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistance10.1038/nmicrobiol.2017.28 ↗
19. Antibiotic-polymer self-assembled nanocomplex to reverse phenotypic resistance of bacteria toward last-resort antibiotic colistin10.1021/acsnano.3c00981 ↗
20. Polyacrylamide-based antimicrobial copolymers to replace or rescue antibiotics10.1021/acscentsci.4c01973 ↗
21. Synthetic antimicrobial polymers in combination therapy: tackling antibiotic resistance10.1021/acsinfecdis.0c00635 ↗
22. Combined efficacy of an antimicrobial cationic peptide polymer with conventional antibiotics to combat multidrug-resistant pathogens10.1021/acsinfecdis.0c00016 ↗
23. Facially amphiphilic bile acid-functionalized antimicrobials: combating pathogenic bacteria, fungi, and their biofilms10.1021/acsinfecdis.3c00266 ↗
24. Controlling macromolecular structures towards effective antimicrobial polymers10.1016/j.polymer.2015.03.007 ↗
25. Recent progress in polymer research to tackle infections and antimicrobial resistance10.1021/acs.biomac.8b00458 ↗
26. Facial amphiphilic naphthoic acid-derived antimicrobial polymers against multi-drug resistant gram-negative bacteria and biofilms10.1016/j.biomaterials.2023.122275 ↗
27. Peptidomimetic polyurethanes inhibit bacterial biofilm formation and disrupt surface established biofilms10.1021/jacs.1c02324 ↗
28. Helical antimicrobial sulfono-γ-AApeptides10.1021/acs.jmedchem.5b00537 ↗
29. Sequence and dispersity are determinants of photodynamic antibacterial activity exerted by peptidomimetic oligo (thiophene) s10.1021/acsami.8b19098 ↗
30. Designer co-beta-peptide copolymer selectively targets resistant and biofilm Gram-negative bacteria10.1016/j.biomaterials.2023.122004 ↗
31. Enantiomeric glycosylated cationic block co-beta-peptides eradicate Staphylococcus aureus biofilms and antibiotic-tolerant persisters10.1038/s41467-019-12702-8 ↗
32. Membrane selectivity of star-shaped peptides: a comparative molecular dynamics study across different bacterial and Mammalian bilayers10.1021/acs.jpcb.5c06308 ↗
33. Antimicrobial cobaltocenium copolymers: tuning amphiphilicity against NDM-1 bacteria10.1039/D5BM00497G ↗
34. Synthesis of cationic cyclic oligo(disulfide)s via cyclo-depolymerization: a redox-responsive and potent antibacterial reagent10.1021/jacs.4c16627 ↗
35. Stimuli-responsive “Arm-First” star copolymers for antibacterial activity and biocompatibility10.1021/acsapm.5c03592 ↗
36. Effect of cyclic topology versus linear terpolymers on antibacterial activity and biocompatibility: antimicrobial peptide avatars10.1039/D4SC05797J ↗
37. Synthetic peptide branched polymers for antibacterial and biomedical applications10.1038/s44222-023-00143-4 ↗
38. Potent racemic antimicrobial polypeptides uncovered by a stereochemical series of cationic d/l backbones10.1021/jacs.5c19741 ↗
39. Imidazole‐rich, four‐armed host‐defense peptidomimetics as promising narrow‐spectrum antibacterial agents and adjuvants against Pseudomonas Aeruginosa infections10.1002/adhm.202400664 ↗
40. Secondary structures in synthetic polypeptides from N-carboxyanhydrides: design, modulation, association, and material applications10.1039/C8CS00095F ↗
41. Persistent bacterial infections and persister cells10.1038/nrmicro.2017.42 ↗
42. Persister cells, dormancy and infectious disease10.1038/nrmicro1557 ↗
43. Definitions and guidelines for research on antibiotic persistence10.1038/s41579-019-0196-3 ↗
44. Synergistic interactions of Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro wound model10.1128/IAI.02198-14 ↗
45. Cross-feeding modulates antibiotic tolerance in bacterial communities10.1038/s41396-018-0212-z ↗
46. Synthetic peptides that form nanostructured micelles have potent antibiotic and antibiofilm activity against polymicrobial infections10.1073/pnas.2219679120 ↗
47. Small molecular adjuvants repurpose antibiotics towards Gram-negative bacterial infections and multispecies bacterial biofilms10.1039/D3SC05124B ↗
48. The past, present, and future of antibiotics10.1126/scitranslmed.abo7793 ↗
49. The BioCyc collection of microbial genomes and metabolic pathways10.1093/bib/bbx085 ↗
50. Heart failure with preserved ejection fraction in pigs causes shifts in posttranscriptional checkpoints10.1152/ajpheart.00551.2023 ↗